Safety of Rt-PA + Transcranial Emission of Low-Energy Lasers for Acute Stroke Recovery "StELLAR"

Terminated

Phase 1/2 Results N/A

Summary of Purpose

To assess the safety and preliminary efficacy of combining intravenous rt-PA with transcranial laser therapy (TLT) with the NeuroThera® Laser System (referred to hereafter as NTS) in subjects treated for acute ischemic stroke. Treatment with IV rt-PA must begin within 3 hours of symptom onset, and the initiation of TLT... Trial Stopped: Device sponsor no longer in business.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 April 2013.

1 Jun 2011 13 Oct 2010 1 Dec 2012 1 Apr 2013 1 Apr 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts